stockrowGenerate Biomedicines, Inc. (GENB) vs Kailera Therapeutics, Inc. (KLRA)
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
- Kailera Therapeutics, Inc. KLRA 12.97 +6.57%
Generate Biomedicines, Inc. and Kailera Therapeutics, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Kailera Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Kailera Therapeutics, Inc. has the higher net margin (0.00% vs −781.1%) and the lower return on invested capital (−182.9% vs 0.00%). Across the 12 metrics below, Kailera Therapeutics, Inc. leads on 9 and Generate Biomedicines, Inc. on 3.
Valuation
Profitability
| Metric | GENB | KLRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 68.51% |
| Operating margin | (751.19%) | 0.00% | 0.00% |
| Net margin | (781.10%) | 0.00% | 0.00% |
| Free cash flow margin | (1,692.17%) | 0.00% | 0.00% |
| Return on equity | 0.00% | (85.74%) | (51.96%) |
| Return on assets | (90.35%) | (55.25%) | (46.06%) |
| Return on invested capital | 0.00% | (182.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack